Keynote review: The adipocyte as a drug discovery target
- 1 September 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 10 (18), 1219-1230
- https://doi.org/10.1016/s1359-6446(05)03569-5
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Adipocyte differentiation induces dynamic changes in NF-κB expression and activityAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Lipid metabolic enzymes: emerging drug targets for the treatment of obesityNature Reviews Drug Discovery, 2004
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Colocalization of insulin receptor and insulin receptor substrate‐1 to caveolae in primary human adipocytesEuropean Journal of Biochemistry, 2004
- The clinical uses of leptinCurrent Opinion in Pharmacology, 2003
- Resistin is expressed in human macrophages and directly regulated by PPARγ activatorsBiochemical and Biophysical Research Communications, 2002
- Falls, Fractures, and Osteoporosis After StrokeStroke, 2002
- Prevention of fat-induced insulin resistance by salicylateJCI Insight, 2001
- Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol ShuttleThe Journal of Experimental Medicine, 1997
- Human Adipocyte Apoptosis Occurs in MalignancyBiochemical and Biophysical Research Communications, 1994